1013 Prognostic value of natural killer cell activity and derived neutrophils-to-lymphocytes ratio in non-small cell lung cancer patients receiving immune checkpoint inhibitors | Zendy

AI Assistant Blog Pricing

1013 Prognostic value of natural killer cell activity and derived neutrophils-to-lymphocytes ratio in non-small cell lung cancer patients receiving immune checkpoint inhibitors

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.